Minimizing the risk of cancer: Tissue architecture and cellular replication limits

Journal of the Royal Society Interface

Volumn 10, Issue 86, 2013, Pages

  Rodriguez Brenes, Ignacio A ^a   Wodarz, Dominik ^a   Komarova, Natalia L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; Cell lineages; Telomeres

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; DISEASES; OPTIMIZATION; TUMORS;

CANCER; CELL LINEAGE; CELL POPULATIONS; CELLULAR REPLICATION; INTERMEDIATE CELLS; MULTICELLULAR ORGANISMS; TELOMERES; TISSUE ARCHITECTURE;

CELLS;

ARTICLE; BASAL CELL CARCINOMA; BASAL LIKE BREAST CANCER; CANCER CELL; CANCER PREVENTION; CANCER RISK; CELL DIFFERENTIATION; CELL DIVISION; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CELL TRANSFORMATION; GLIOBLASTOMA; HOMEOSTASIS; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; PROSTATE CANCER; SOMATIC CELL; STEADY STATE; STEM CELL; STEM CELL NICHE; TELOMERE; TISSUE ARCHITECTURE; TISSUE REGENERATION; TISSUE STRUCTURE; TURNOVER TIME; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; METABOLISM; NEOPLASM; PATHOLOGY; RISK FACTOR; CELL LINEAGES; TELOMERES;

TELOMERASE; TUMOR PROTEIN;

ANIMALS; CELL DIVISION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; NEOPLASMS; RISK FACTORS; TELOMERASE;

CANCER; CELL LINEAGES; TELOMERES;

EID: 84880793397     PISSN: 17425689     EISSN: 17425662     Source Type: Journal    
DOI: 10.1098/rsif.2013.0410     Document Type: Article

References (55)

1. Hayflick L, Moorhead P. 1961 Serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585-621. (doi:10.1016/0014-4827(61)90192-6).
2. Harley CB, Futcher AB, Greider CW. 1990 Telomeres shorten during ageing of human fibroblasts. Nature 345, 458-460. (doi:10.1038/345458a0).
3. Blackburn E. 1991 Structure and function of telomeres. Nature 350, 569-573. (doi:10.1038/350569a0).
4. de Lange T. 2005 Shelterin: The protein complex that shapes and safeguards human telomeres. Genes Dev. 19, 2100-2110. (doi:10.1101/gad. 1346005).
5. Olovnikov AM. 1973 A theory of marginotomy: The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol. 41, 181-190. (doi:10.1016/0022-5193(73)90198-7).
6. Makarov V, Hirose Y, Langmore J. 1997 Long g tails at both ends of human chromosomes suggest a c strand degradation mechanism for telomere shortening. Cell 88 657-666. (doi:10.1016/S0092- 8674(00)81908-X).
7. von Zglinicki T. 2002 Oxidative stress shortens telomeres. Trends Biochem. Sci. 27, 339-344. (doi:10.1016/S0968-0004(02)02110-2).
8. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S. 1992 Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11, 1921-1929.
9. Chin K et al. 2004 In situ analyses of genome instability in breast cancer. Nat. Genet. 36, 984- 988. (doi:10.1038/ng1409).
10. Piatyszek M, Prowse K, Harley C, West M, Ho P, Coviello G, Wright W, Weinrich S, Shay J. 1994 Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015. (doi:10.1126/science. 7605428).
11. Reya T, Morrison S, Clarke M, Weissman I. 2001 Stem cells, cancer, and cancer stem cells. Nature 414, 105-111. (doi:10.1038/35102167).
12. Shizuru JA, Negrin RS, Weissman IL. 2005 Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system. Annu. Rev. Med. 56, 509-538. (doi:10. 1146/annurev.med.54.101601.152334) .
13. Frank SA. 2007 Dynamics of cancer: incidence, inheritance, and evolution. Princeton, NJ: Princeton University Press.
14. Passegué E, Wagers AJ, Giuriato S, Anderson WC, Weissman IL. 2005 Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J. Exp. Med. 202, 1599-1611. (doi:10.1084/jem. 20050967).
15. Gage F. 2000 Mammalian neural stem cells. Science 287, 1433-1438. (doi:10.1126/science.287.5457. 1433).
16. Potten C, Booth C. 2002 Keratinocyte stem cells: a commentary. J. Invest. Dermatol. 119, 888-899. (doi:10.1046/j.1523-1747.2002.00020.x).
17. Okumura T, Shimada Y, Imamura M, Yasumoto S. 2003 Neurotrophin receptor p75NTR characterizes human esophageal keratinocyte stem cells in vitro. Oncogene 22, 4017-4026. (doi:10.1038/sj.onc.1206525).
18. Marshman E, Booth C, Potten C. 2002 The intestinal epithelial stem cell. Bioessays 24, 91-98. (doi:10. 1002/bies.10028).
19. Reya T, Clevers H. 2005 Wnt signalling in stem cells and cancer. Nature 434, 843-850. (doi:10.1038/nature03319).
20. Johnston MD, Edwards CM, Bodmer WF, Maini PK, Chapman SJ. 2007 Mathematical modeling of cell population dynamics in the colonic crypt and in colorectal cancer. Proc. Natl Acad. Sci. USA 104, 4008-4013. (doi:10.1073/pnas.0611179104).
21. Marciniak-Czochra A, Stiehl T, Ho AD, Jäger W, Wagner W. 2009 Modeling of asymmetric cell division in hematopoietic stem cells-regulation of self-renewal is essential for efficient repopulation. Stem Cells Dev. 18, 377-385. (doi:10.1089/scd. 2008.0143).
22. Lander AD, Gokoffski KK, Wan FYM, Nie Q, Calof AL. 2009 Cell lineages and the logic of proliferative control. PLoS Biol. 7, e15. (doi:10.1371/journal. pbio. 1000015).
23. Bocharov G, Quiel J, Luzyanina T, Alon H, Chiglintsev E, Chereshnev V, Meier-Schellersheim M, Paul WE, Grossman Z. 2011 Feedback regulation of proliferation vs. differentiation rates explains the dependence of CD4 T-cell expansion on precursor number. Proc. Natl Acad. Sci. USA 108, 3318-3323. (doi:10.1073/pnas.1019706108).
24. Rodriguez-Brenes IA, Komarova NL, Wodarz D. 2011 Evolutionary dynamics of feedback escape and the development of stem-cell-driven cancers. Proc. Natl Acad. Sci. USA 108, 18983-18988. (doi:10.1073/pnas.1107621108).
25. Werner B, Dingli D, Lenaerts T, Pacheco JM, Traulsen A. 2011 Dynamics of mutant cells in hierarchical organized tissues. PLoS Comput. Biol. 7, e1002290. (doi:10.1371/journal.pcbi.1002290).
26. McPherron AC, Lawler AM, Lee SJ. 1997 Regulation of skeletal muscle mass in mice by a new TGF-b superfamily member. Nature 387, 83-90. (doi:10. 1038/387083a0).
27. Wu H-H, Ivkovic S, Murray RC, Jaramillo S, Lyons KM, Johnson JE, Calof AL. 2003 Autoregulation of neurogenesis by GDF11. Neuron 37, 197-207. (doi:10.1016/S0896-6273(02)01172-8).
28. Smogorzewska A, de Lange T. 2002 Different telomere damage signaling pathways in human and mouse cells. EMBO J. 21, 4338-4348. (doi:10.1093/emboj/ cdf433).
29. Marciniak-Czochra A, Stiehl T, Wagner W. 2009 Modeling of replicative senescence in hematopoietic development. Aging (Albany NY) 1, 723-732.
30. Glauche I, Thielecke L, Roeder I. 2011 Cellular aging leads to functional heterogeneity of hematopoietic stem cells: a modeling perspective. Aging Cell 10, 457-465. (doi:10.1111/j.1474-9726.2011.00692.x).
31. Enderling H, Hlatky L, Hahnfeldt P. 2009 Migration rules: Tumours are conglomerates of selfmetastases. Br. J. Cancer 100, 1917-1925. (doi:10. 1038/sj.bjc.6605071).
32. Arkus N. 2005 A mathematical model of cellular apoptosis and senescence through the dynamics of telomere loss. J. Theor. Biol. 235, 13-32. (doi:10. 1016/j.jtbi.2004.12.016).
33. Olofsson P, Kimmel M. 1999 Stochastic models of telomere shortening. Math. Biosci. 158, 75-92. (doi:10.1016/S0025-5564(98)10092-5).
34. Rodriguez-Brenes IA, Peskin CS. 2010 Quantitative theory of telomere length regulation and cellular senescence. Proc. Natl Acad. Sci. USA 107, 5387- 5392. (doi:10.1073/pnas.0914502107).
35. Proctor CJ, Kirkwood TBL. 2002 Modelling telomere shortening and the role of oxidative stress. Mech. Ageing Dev. 123, 351-363. (doi:10.1016/S0047- 6374(01)00380-3).
36. Huffman KE, Levene SD, Tesmer VM, Shay JW, Wright WE. 2000 Telomere shortening is proportional to the size of the g-rich telomeric 3'-overhang. J. Biol. Chem. 275, 19 719-19 722. (doi:10.1074/jbc.M002843200).
37. Bach SP, Renehan AG, Potten CS. 2000 Stem cells: The intestinal stem cell as a paradigm. Carcinogenesis 21, 469-476. (doi:10.1093/carcin/21.3.469).
38. Komarova NL, Wang L. 2004 Initiation of colorectal cancer: where do the two hits hit? Cell Cycle 3, 1558-1565. (doi:10.4161/cc.3.12.1186).
39. Visvader JE. 2011 Cells of origin in cancer. Nature 469, 314-322. (doi:10.1038/nature09781).
40. Guibal FC et al. 2009 Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia. Blood 114, 5415- 5425. (doi:10.1182/blood-2008-10-182071).
41. Krivtsov AV et al. 2006 Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442, 818-822. (doi:10.1038/nature04980).
42. Goardon N et al. 2011 Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. Cancer Cell 19, 138-152. (doi:10.1016/j. ccr.2010.12.012).
43. Wojiski S, Guibal FC, Kindler T, Lee BH, Jesneck JL, Fabian A, Tenen DG, Gilliland DG. 2009 PML-RARa initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors. Leukemia 23, 1462-1471. (doi:10.1038/leu.2009.63).
44. Huntly BJP et al. 2004 MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 6, 587-596. (doi:10.1016/j.ccr.2004.10.015).
45. Cozzio A, Passegué E, Ayton PM, Karsunky H, Cleary ML, Weissman IL. 2003 Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev. 17, 3029-3035. (doi:10.1101/gad.1143403).
46. Friedmann-Morvinski D, Bushong EA, Ke E, Soda Y, Marumoto T, Singer O, Ellisman MH, Verma IM. 2012 Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Science 338, 1080-1084. (doi:10.1126/science.1226929).
47. Schüller U et al. 2008 Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form shh-induced medulloblastoma. Cancer Cell 14, 123-134. (doi:10.1016/j.ccr.2008. 07.005).
48. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON. 2010 Identification of a cell of origin for human prostate cancer. Science 329, 568-571. (doi:10. 1126/science.1189992).
49. Youssef KK, Van Keymeulen A, Lapouge G, Beck B, Michaux C, Achouri Y, Sotiropoulou PA, Blanpain C. 2010 Identification of the cell lineage at the origin of basal cell carcinoma. Nat. Cell Biol. 12, 299-305. (doi:10.1038/ncb2031).
50. Lim E et al. 2009 Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat. Med. 15, 907-913. (doi:10.1038/nm.2000).
51. Flores I, Benetti R, Blasco MA. 2006 Telomerase regulation and stem cell behaviour. Curr. Opin. Cell Biol. 18, 254-260. (doi:10.1016/j.ceb.2006.03.003).
52. Flores I, Canela A, Vera E, Tejera A, Cotsarelis G, Blasco MA. 2008 The longest telomeres: a general signature of adult stem cell compartments. Genes Dev. 22, 654-667. (doi:10.1101/gad.451008).
53. Lobo NA, Shimono Y, Qian D, Clarke MF. 2007 The biology of cancer stem cells. Annu. Rev. Cell Dev. Biol. 23, 675-699. (doi:10.1146/annurev.cellbio.22. 010305.104154).
54. England SJ, McGrath KE, Frame JM, Palis J. 2011 Immature erythroblasts with extensive ex vivo selfrenewal capacity emerge from the early mammalian fetus. Blood 117, 2708-2717. (doi:10.1182/blood- 2010-07-299743).
55. Sanai N, Alvarez-Buylla A, Berger MS. 2005 Neural stem cells and the origin of gliomas. N. Engl. J. Med. 353, 811-822. (doi:10.1056/NEJMra043666).